COVID-19

News

J&J and US government invest $1 billion in COVID-19 vaccine

Johnson & Johnson has announced plans to team up with the US government to invest more than $1 billion in a new vaccine against COVID-19, aiming to begin clinical trials by September.<

News

Sanofi begins trial of Kevzara against COVID-19 complication...

Sanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab) in patients hospitalised with severe disease.

News

Pharma companies that don’t change during COVID-19 will be ‘...

Janssen’s former clinical innovation VP Andreas Koester has warned that pharma companies that go back to how they were working before the COVID-19 crisis could soon find themselves irrelevant on

News

COVID-19 could cause ‘digital reset’ for pharma

The COVID-19 crisis will lead to a “digital reset” in pharma that will completely change how companies interact with customers, according to Indegene’s VP strategy and applied digital transforma

News

FDA grants emergency use of malaria drugs against COVID-19

The FDA has approved emergency use of malaria drugs championed by president Donald Trump for use in patients hospitalised with COVID-19, after warning against the potentially lethal consequ

Views & Analysis

What HCPs think about shortages from COVID-19

Much has been said about COVID-19 by healthcare professionals (HCPs) online: the most recent issue to grab their attention has been shortages caused by stockpiling or panic buying.

J&J and US government invest $1 billion in COVID-19 vaccine

Sanofi begins trial of Kevzara against COVID-19 complication...

Pharma companies that don’t change during COVID-19 will be ‘...

COVID-19 could cause ‘digital reset’ for pharma

FDA grants emergency use of malaria drugs against COVID-19

What HCPs think about shortages from COVID-19

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks